New exosome isolation and detection kits have been developed by AMSBIO to assist researchers in targeted cancer therapy. This therapy technique delivers drugs to specific carriers and disrupts the target molecules. These target molecules are involved in tumor development and progression.
Exosomes that express specific surface markers such as CD81, CD63, and CD9 have been demonstrated to participate in tumorigenesis and cancer progression as a transporter of miRNA. This makes them a promising delivery system as a carrier of immunotherapy, chemotherapy, and cancer vaccines.